Effect of Rate-responsive Compared to VDD Pacing in Cardiac Resynchronization Therapy Recipients
1 other identifier
interventional
26
1 country
1
Brief Summary
This study aims to understand the best programming pacing mode for cardiac resynchronization therapy devices used to treat chronic heart failure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 27, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 17, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 17, 2021
CompletedFirst Submitted
Initial submission to the registry
September 6, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedSeptember 19, 2024
September 1, 2024
3.8 years
September 6, 2024
September 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
distance walked during the 6MWT
distance walked during the 6-minute-walking-test (6MWT)
A consecutive 6-month treatment period with the same pacing mode.
Study Arms (2)
VDD
ACTIVE COMPARATORA pacing mode which allows sensing of intrinsic sinus rhythm as much as possible to avoid unnecessary atrial pacing is the preferred programming in patients with CRT without atrial pacing indication. VDD pacing mode met these criteria.
DDDR
EXPERIMENTALDDDR pacing mode added atrial support to these using an accelerometer-based rate-responsive sensor which should be able to increase heart rate when needed.
Interventions
Use a pacing mode with atrial pacing including a rate-resposive sensor.
A pacing mode which allows sensing of intrinsic sinus rhythm as much as possible to avoid unnecessary atrial pacing is the preferred programming in patients with CRT without atrial pacing indication. VDD pacing mode met these criteria.
Eligibility Criteria
You may qualify if:
- Patients willing to participate in the study and signing the approved Patient Informed Consent (PIC) Form;
- Patients with approved indication for CRT by European Society of Cardiology/European Heart Rhythm Association guidelines (ESC/EHRA).
- Sinus rhythm at the time of CRT device implantation with heart rate at rest above 50 bpm.
You may not qualify if:
- Permanent Atrial Fibrillation;
- Inability to perform 6MWT;
- Suboptimal HF drug therapy;
- Heart rate at rest above 50 bpm.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ospedale Centrale di Bolzano
Bolzano, Italy
Related Publications (1)
Donazzan L, Bulian F, Maines M, Erckert M, Peruzza F, Rauhe WG, Giacopelli D, Manfrin M. Effect of rate-adaptive atrial support compared to VDD pacing in cardiac resynchronization therapy recipients: A randomized cross-over study. Am Heart J. 2025 Mar;281:149-156. doi: 10.1016/j.ahj.2024.12.005. Epub 2024 Dec 17.
PMID: 39701488DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Cardiologist
Study Record Dates
First Submitted
September 6, 2024
First Posted
September 19, 2024
Study Start
November 27, 2017
Primary Completion
September 17, 2021
Study Completion
September 17, 2021
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share
Privacy concerns.